Tiziana Life Sciences Ltd (NASDAQ:TLSA) Short Interest Update

Tiziana Life Sciences Ltd (NASDAQ:TLSA) saw a large decrease in short interest in April. As of April 15th, there was short interest totalling 257,800 shares, a decrease of 20.0% from the March 31st total of 322,200 shares. Based on an average trading volume of 149,600 shares, the days-to-cover ratio is currently 1.7 days.

Tiziana Life Sciences Trading Down 7.3 %

TLSA opened at $0.78 on Monday. The stock has a 50-day moving average of $0.52 and a 200-day moving average of $0.57. Tiziana Life Sciences has a 52-week low of $0.41 and a 52-week high of $1.27.

About Tiziana Life Sciences

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases.